FH Ortho Receives Japanese Regulatory Clearance for Arrow Prime Anatomic Shoulder System

FH Ortho, a manufacturer of orthopedic devices and instruments for surgeons, has received approval from the Pharmaceuticals and Medical Devices Agency of Japan to market the Arrow Prime Anatomic Shoulder System to treat complex fractured shoulder reconstructions and total joint replacements resulting from wear or trauma.
 
“The approval of Arrow Prime in Japan represents another exciting opportunity to further grow our presence in the global market,” said Jean-Marc Idier, president Group FH Ortho. “Our goal is to design innovative implants that are simple and easy to use with reproducible results for a broad range of patients and I believe we have achieved this with the Arrow Prime Shoulder System.”
 
More than 24,000 cases have been performed worldwide with the Arrow Shoulder System since 2003, with over 15 years of clinical data.
 
FH Ortho develops and manufactures orthopedic devices and instruments for surgeons around the world. Founded in Mulhouse, France, in 1964, FH Ortho is represented in over 37 countries, with products focused on joint reconstruction, ligament repair, biologics, foot & ankle, spine, and trauma surgery. Backed by 55 years of forward-thinking innovation in devices, techniques and product delivery, the company today is positioned for rapid expansion globally. FH Ortho products are developed and refined by surgeon experts who are among the world leaders in their respective fields. FH products help surgeons deliver ideal patient outcomes with devices, systems and tools that simplifies patient management for the surgeon, at an overall cost structure that is a benefit to the entire patient continuum of care.